{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:25:38Z","timestamp":1789230338031,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100019345","name":"King Salman Center for Disability Research","doi-asserted-by":"publisher","award":["KSRG-2024-340"],"award-info":[{"award-number":["KSRG-2024-340"]}],"id":[{"id":"10.13039\/501100019345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22955-7","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:19:45Z","timestamp":1763133585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of novel neuraminidase 1 modulators as potential therapeutics for Alzheimer\u2019s disease using virtual screening and molecular dynamics simulations"],"prefix":"10.1038","volume":"15","author":[{"given":"Sami I.","family":"Alzarea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"22955_CR1","doi-asserted-by":"crossref","unstructured":"Tahami Monfared, A. A., Byrnes, M. J., White, L. A. & Zhang, Q. J. N.  Therapy. Alzheimer\u2019s Dis. Epidemiol. Clin. Prog. 11, 553\u2013569 (2022).","DOI":"10.1007\/s40120-022-00338-8"},{"key":"22955_CR2","doi-asserted-by":"publisher","first-page":"1078987","DOI":"10.3389\/fmolb.2022.1078987","volume":"9","author":"R Shukla","year":"2023","unstructured":"Shukla, R., Kumar, A., Kelvin, D. J. & Singh, T. R. Disruption of DYRK1A-induced hyperphosphorylation of amyloid-beta and tau protein in Alzheimer\u2019s disease: An integrative molecular modeling approach. Front. Mol. Biosci. 9, 1078987 (2023).","journal-title":"Front. Mol. Biosci."},{"key":"22955_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jmgm.2019.06.008","volume":"91","author":"R Shukla","year":"2019","unstructured":"Shukla, R., Munjal, N. S. & Singh, T. R. Identification of novel small molecules against GSK3\u03b2 for Alzheimer\u2019s disease using chemoinformatics approach. J. Mol. Graphics Modelling. 91, 91\u2013104 (2019).","journal-title":"J. Mol. Graphics Modelling"},{"key":"22955_CR4","doi-asserted-by":"crossref","unstructured":"Bustamante, H. A. et al. Interplay between the autophagy-lysosomal pathway and the ubiquitin-proteasome system: A target for therapeutic development in Alzheimer\u2019s disease. Front Cell Neurosci. 12, 126 (2018).","DOI":"10.3389\/fncel.2018.00126"},{"key":"22955_CR5","doi-asserted-by":"crossref","unstructured":"Papaevgeniou, N. & Chondrogianni, N. UPS activation in the battle against aging and aggregation-related diseases: An extended review.  Methods Mol Biol. 1\u201370 (2016).","DOI":"10.1007\/978-1-4939-3756-1_1"},{"key":"22955_CR6","doi-asserted-by":"crossref","unstructured":"Bhatia, V. & Sharma, S. J.  Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer\u2019s disease. J Neurol Sci. 421, 117253 (2021).","DOI":"10.1016\/j.jns.2020.117253"},{"key":"22955_CR7","doi-asserted-by":"crossref","unstructured":"Engin, A. B., Engin, A.  Alzheimer\u2019s disease and protein kinases. Adv Exp Med Biol. 285-321 (2021).","DOI":"10.1007\/978-3-030-49844-3_11"},{"key":"22955_CR8","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nn.2583","volume":"13","author":"JJ Palop","year":"2010","unstructured":"Palop, J. J. & Mucke, L. J. Amyloid-\u03b2\u2013induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks. Nat Neurosci. 13, 812\u2013818 (2010).","journal-title":"Nat Neurosci."},{"key":"22955_CR9","doi-asserted-by":"crossref","unstructured":"Smutova, V. et al. Structural basis for substrate specificity of mammalian neuraminidases. PLoS One. 9, e106320 (2014).","DOI":"10.1371\/journal.pone.0106320"},{"key":"22955_CR10","doi-asserted-by":"crossref","unstructured":"Toussaint, K. et al. Neuraminidase-1: A sialidase involved in the development of cancers and metabolic diseases. Cancers (Basel). 14, 4868 (2022).","DOI":"10.3390\/cancers14194868"},{"key":"22955_CR11","doi-asserted-by":"crossref","unstructured":"Miyagi, T. et al. Biological and pathological roles of ganglioside sialidases. Prog Mol Biol Transl Sci. 156, 121\u2013150 (2018).","DOI":"10.1016\/bs.pmbts.2017.12.005"},{"key":"22955_CR12","doi-asserted-by":"crossref","unstructured":"Zanchetti, G. et al. Sialidase NEU3 is a peripheral membrane protein localized on the cell surface and in endosomal structures. Biochem J. 408, 211\u2013219 (2007).","DOI":"10.1042\/BJ20070503"},{"key":"22955_CR13","doi-asserted-by":"crossref","unstructured":"Monti, E., Preti, A., Nesti, C., Ballabio, A. & Borsani, G. Expression of a novel human sialidase encoded by the NEU2 gene. Glycobiology. 9, 1313\u20131321 (1999).","DOI":"10.1093\/glycob\/9.12.1313"},{"key":"22955_CR14","doi-asserted-by":"crossref","unstructured":"Magesh, S. et al. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors. J Mol Graph Model. 25, 196\u2013207 (2006).","DOI":"10.1016\/j.jmgm.2005.12.006"},{"key":"22955_CR15","doi-asserted-by":"crossref","unstructured":"Du, J. et al. Neuraminidase-1 (NEU1): Biological roles and therapeutic relevance in human disease. Curr Issues Mol Biol. 46, 8031\u20138052 (2024).","DOI":"10.3390\/cimb46080475"},{"key":"22955_CR16","doi-asserted-by":"crossref","unstructured":"Khan, A. & Sergi, C. M.  NEU1\u2014A unique therapeutic target for Alzheimer\u2019s disease. Front Pharmacol. 13, 902259 (2022).","DOI":"10.3389\/fphar.2022.902259"},{"key":"22955_CR17","doi-asserted-by":"crossref","unstructured":"Lemke, G. & Huang, Y. The dense-core plaques of alzheimer\u2019s disease are granulomas. J Exp Med. 219, e20212477 (2022).","DOI":"10.1084\/jem.20212477"},{"key":"22955_CR18","unstructured":"Hwu, W. L. et al. Gene therapy corrects the neurological deficits of mice with sialidosis. Gene Ther. 1\u201310 (2024)."},{"key":"22955_CR19","unstructured":"Afram, E. The Implication of the \u03b7CTF Fragment in Alzheimer\u2019s Disease: Study of Its Expression, Localization, and Degradation (Universit\u00e9 C\u00f4te d\u2019Azur, 2023)."},{"key":"22955_CR20","doi-asserted-by":"crossref","unstructured":"Khan, A., Das, S. & Sergi, C. Therapeutic potential of Neu1 in Alzheimer\u2019s disease via the immune system. Am. J. Alzheimers Dis. Other Demen. 36, 1533317521996147 (2021).","DOI":"10.1177\/1533317521996147"},{"key":"22955_CR21","doi-asserted-by":"crossref","unstructured":"Annunziata, I. et al. Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-\u03b2 secretion via deregulated lysosomal exocytosis. Nat Commun. 4, 2734 (2013).","DOI":"10.1038\/ncomms3734"},{"key":"22955_CR22","doi-asserted-by":"crossref","unstructured":"Guo, T. et al. Selective inhibitors of human neuraminidase 1 (NEU1). J Med Chem. 61, 11261\u201311279 (2018).","DOI":"10.1021\/acs.jmedchem.8b01411"},{"key":"22955_CR23","doi-asserted-by":"crossref","unstructured":"Albrecht, C. et al. Transmembrane peptides as a new strategy to inhibit neuraminidase-1 activation. Front Cell Dev Biol. 8, 611121 (2020).","DOI":"10.3389\/fcell.2020.611121"},{"key":"22955_CR24","doi-asserted-by":"crossref","unstructured":"Bharadwaj, K. K. et al. Potent bioactive compounds from seaweed waste to combat cancer through bioinformatics investigation.  Front Nutr.  9, 889276 (2022).","DOI":"10.3389\/fnut.2022.889276"},{"key":"22955_CR25","doi-asserted-by":"crossref","unstructured":"Lomartire, S. & Gon\u00e7alves, A. M. J. M. D. An overview of potential seaweed-derived bioactive compounds for pharmaceutical applications. Mar Drugs. 20, 141 (2022).","DOI":"10.3390\/md20020141"},{"key":"22955_CR26","doi-asserted-by":"publisher","first-page":"132761","DOI":"10.1016\/j.molstruc.2022.132761","volume":"1260","author":"S Islam","year":"2022","unstructured":"Islam, S. et al. Synthesis, antimicrobial, anticancer activities, PASS prediction, molecular docking, molecular dynamics and pharmacokinetic studies of designed methyl \u03b1-D-glucopyranoside esters. J. Mol. Struct. 1260, 132761 (2022).","journal-title":"J. Mol. Struct."},{"key":"22955_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3329\/bjp.v9i4.20412","volume":"9","author":"B Ahmed","year":"2014","unstructured":"Ahmed, B., Ashfaq, U. A., ul Qamar, M. T. & Ahmad, M. Anticancer potential of phytochemicals against breast cancer: molecular docking and simulation approach. Bangladesh J. Pharmacol. 9, 545\u2013550 (2014).","journal-title":"Bangladesh J. Pharmacol."},{"key":"22955_CR28","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1080\/07391102.2023.2198017","volume":"42","author":"Y Bashir","year":"2024","unstructured":"Bashir, Y. et al. Integrated virtual screening and molecular dynamics simulation approaches revealed potential natural inhibitors for DNMT1 as therapeutic solution for triple negative breast cancer. J. Biomol. Struct. Dynamics. 42, 1099\u20131109 (2024).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"22955_CR29","doi-asserted-by":"publisher","first-page":"716735","DOI":"10.3389\/fmolb.2021.716735","volume":"8","author":"I Muneer","year":"2021","unstructured":"Muneer, I. et al. Discovery of novel inhibitors from medicinal plants for v-domain Ig suppressor of t-cell activation. Front. Mol. Biosci. 8, 716735 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"22955_CR30","doi-asserted-by":"publisher","first-page":"107059","DOI":"10.1016\/j.compbiomed.2023.107059","volume":"161","author":"M Sadaqat","year":"2023","unstructured":"Sadaqat, M. et al. Advanced network Pharmacology study reveals multi-pathway and multi-gene regulatory molecular mechanism of Bacopa monnieri in liver cancer based on data mining, molecular modeling, and microarray data analysis. Computers Biology Med. 161, 107059 (2023).","journal-title":"Computers Biology Med."},{"key":"22955_CR31","doi-asserted-by":"crossref","unstructured":"Altharawi, A., Ahmad, S.,  Alamri, M. A. & Ul Qamar, M. T. Structural insight into the binding pattern and interaction mechanism of chemotherapeutic agents with Sorcin by Docking and molecular dynamic simulation. Colloids Surf. B: Biointerfaces. 208, 112098 (2021).","DOI":"10.1016\/j.colsurfb.2021.112098"},{"key":"22955_CR32","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1021\/acs.jmedchem.5b00952","volume":"58","author":"P Singh","year":"2015","unstructured":"Singh, P., Kaur, J., Singh, G. & Bhatti, R. Triblock conjugates: identification of a highly potent antiinflammatory agent. J. Med. Chem. 58, 5989\u20136001 (2015).","journal-title":"J. Med. Chem."},{"key":"22955_CR33","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1021\/acs.jmedchem.6b00134","volume":"59","author":"P Singh","year":"2016","unstructured":"Singh, P., Kaur, S., Kaur, J., Singh, G. & Bhatti, R. Rational design of small peptides for optimal Inhibition of cyclooxygenase-2: development of a highly effective anti-inflammatory agent. J. Med. Chem. 59, 3920\u20133934 (2016).","journal-title":"J. Med. Chem."},{"key":"22955_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bmcl.2017.11.049","volume":"28","author":"J Kaur","year":"2018","unstructured":"Kaur, J., Kaur, B. & Singh, P. Rational modification of semaxanib and Sunitinib for developing a tumor growth inhibitor targeting ATP binding site of tyrosine kinase. Bioorg. Med. Chem. Lett. 28, 129\u2013133 (2018).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"22955_CR35","doi-asserted-by":"publisher","first-page":"115431","DOI":"10.1016\/j.molliq.2021.115431","volume":"329","author":"S Arti","year":"2021","unstructured":"Arti, S. et al. Host-guest interaction of Trimethoprim drug with cyclodextrins in aqueous solutions: Calorimetric, spectroscopic, volumetric and theoretical approach. J. Mol. Liq. 329, 115431 (2021).","journal-title":"J. Mol. Liq."},{"key":"22955_CR36","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/j.bmcl.2016.03.015","volume":"26","author":"J Kaur","year":"2016","unstructured":"Kaur, J., Kaur, S. & Singh, P. Rational modification of the lead molecule: enhancement in the anticancer and dihydrofolate reductase inhibitory activity. Bioorg. Med. Chem. Lett. 26, 1936\u20131940 (2016).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"22955_CR37","doi-asserted-by":"publisher","first-page":"28321","DOI":"10.1038\/s41598-024-79799-w","volume":"14","author":"F Noor","year":"2024","unstructured":"Noor, F. et al. Deep learning pipeline for accelerating virtual screening in drug discovery. Sci. Rep. 14, 28321 (2024).","journal-title":"Sci. Rep."},{"key":"22955_CR38","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/07391102.2023.2208203","volume":"42","author":"A Majeed","year":"2024","unstructured":"Majeed, A. et al. Structural insights into the mechanism of resistance to bicalutamide by the clinical mutations in androgen receptor in chemo-treatment resistant prostate cancer. J. Biomol. Struct. Dynamics. 42, 1181\u20131190 (2024).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"22955_CR39","doi-asserted-by":"publisher","first-page":"11261","DOI":"10.1021\/acs.jmedchem.8b01411","volume":"61","author":"T Guo","year":"2018","unstructured":"Guo, T. et al. Selective inhibitors of human neuraminidase 1 (NEU1). J. Med. Chem. 61, 11261\u201311279 (2018).","journal-title":"J. Med. Chem."},{"key":"22955_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"22955_CR41","unstructured":"Ravi, L. & Kannabiran, K. A handbook on protein-ligand docking tool: AutoDock 4. Innovare J. Med. Sci. 4, 28\u201333 (2016)."},{"key":"22955_CR42","doi-asserted-by":"crossref","unstructured":"Van Der Spoel, D. et al. GROMACS: Fast, flexible, and free. J. Comput. Chem. 26,  1701\u20131718 (2005).","DOI":"10.1002\/jcc.20291"},{"key":"22955_CR43","unstructured":"Laskowski, R., MacArthur, M. & Thornton, J. PROCHECK: Validation of protein-structure coordinates. (2006)."},{"key":"22955_CR44","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/ijms25020797","volume":"25","author":"J Cotas","year":"2024","unstructured":"Cotas, J., Lomartire, S., Gon\u00e7alves, A. M. & Pereira, L. From ocean to medicine: Harnessing seaweed\u2019s potential for drug development. Int. J. Mol. Sci. 25, 797 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"22955_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/md17060373","volume":"17","author":"N Besednova","year":"2019","unstructured":"Besednova, N. et al. Metabolites of seaweeds as potential agents for the prevention and therapy of influenza infection. Mar. Drugs. 17, 373 (2019).","journal-title":"Mar. Drugs"},{"key":"22955_CR46","doi-asserted-by":"publisher","first-page":"131840","DOI":"10.1016\/j.ijbiomac.2024.131840","volume":"269","author":"OA Durojaye","year":"2024","unstructured":"Durojaye, O. A. et al. Investigation of the MDM2-binding potential of de Novo designed peptides using enhanced sampling simulations. Int. J. Biol. Macromol. 269, 131840 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"22955_CR47","doi-asserted-by":"crossref","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 7, 42717 (2017).","DOI":"10.1038\/srep42717"},{"key":"22955_CR48","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jcc.21367","volume":"31","author":"K Vanommeslaeghe","year":"2010","unstructured":"Vanommeslaeghe, K. et al. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all\u2010atom additive biological force fields. J. Comput. Chem. 31, 671\u2013690 (2010).","journal-title":"J. Comput. Chem."},{"key":"22955_CR49","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1021\/ct300400x","volume":"8","author":"RB Best","year":"2012","unstructured":"Best, R. B. et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03d5, \u03c8 and side-chain \u03c71 and \u03c72 dihedral angles. J. Chem. Theory Comput. 8, 3257\u20133273 (2012).","journal-title":"J. Chem. Theory Comput."},{"key":"22955_CR50","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/biom.12641","volume":"73","author":"P Sang","year":"2017","unstructured":"Sang, P., Wang, L. & Cao, J. Parametric functional principal component analysis. Biometrics 73, 802\u2013810 (2017).","journal-title":"Biometrics"},{"key":"22955_CR51","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco, M. S., Vald\u00e9s-Tresanco, M. E., Valiente, P. A. & Moreno, E. gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J. Chem. Theory Comput. 17, 6281\u20136291 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"22955_CR52","doi-asserted-by":"crossref","unstructured":"Stein, R. M. et al. Property-unmatched decoys in Docking benchmarks.  J Chem Inf Model. 61, 699\u2013714 (2021).","DOI":"10.1021\/acs.jcim.0c00598"},{"key":"22955_CR53","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1021\/ja8085643","volume":"131","author":"RE Amaro","year":"2009","unstructured":"Amaro, R. E., Cheng, X., Ivanov, I., Xu, D. & McCammon, J. A. Characterizing loop dynamics and ligand recognition in human-and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations. J. Am. Chem. Soc. 131, 4702\u20134709 (2009).","journal-title":"J. Am. Chem. Soc."},{"key":"22955_CR54","doi-asserted-by":"crossref","unstructured":"Maurice, P. et al. New Insights into Molecular Organization of Human Neuraminidase-1: Transmembrane Topology and Dimerization Ability. Sci Rep. 6, 38363 (2016).","DOI":"10.1038\/srep38363"},{"key":"22955_CR55","doi-asserted-by":"publisher","first-page":"113320","DOI":"10.1016\/j.ejmech.2021.113320","volume":"216","author":"S Srivastava","year":"2021","unstructured":"Srivastava, S., Ahmad, R. & Khare, S. K. Alzheimer\u2019s disease and its treatment by different approaches: A review. Eur. J. Med. Chem. 216, 113320 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"22955_CR56","doi-asserted-by":"publisher","first-page":"902259","DOI":"10.3389\/fphar.2022.902259","volume":"13","author":"A Khan","year":"2022","unstructured":"Khan, A. & Sergi, C. M. NEU1\u2014A unique therapeutic target for alzheimer\u2019s disease. Front. Pharmacol. 13, 902259 (2022).","journal-title":"Front. Pharmacol."},{"key":"22955_CR57","doi-asserted-by":"crossref","unstructured":"Amaro, R. E., Cheng, X., Ivanov, I., Xu, D. & McCammon, J. A. Characterizing loop dynamics and ligand recognition in human-and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations. J. Am. Chem. Soc. , 4702\u20134709 (2009).","DOI":"10.1021\/ja8085643"},{"key":"22955_CR58","first-page":"1551","volume":"3","author":"Y Wu","year":"2013","unstructured":"Wu, Y. et al. Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding. Sci. Rep. 3, 1551 (2013).","journal-title":"Sci. Reportss"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22955-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22955-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22955-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:06:17Z","timestamp":1763510777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22955-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22955"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22955-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39901"}}